Trpv1 Agonist Compounds, Formulations, Prodrugs, Methods For Using The Same

Abstract

Described here are TRPV1 agonist compounds and their methods of synthesis and use. In addition to specifically identified compounds, capsaicin prodrugs, gemini dimers, and mutual prodrugs are also described. Formulations of the TRPV1 agonist compounds may be in the form of a liquid, tablets, capsules, gel, cream, emulsion, a patch, or the like. Methods for treating medical conditions using the compounds, compositions, or prodrugs described, are also provided.


Claims
Download PDF
Document Preview
Document History
  • Publication: Dec 15, 2009
  • Application: Apr 25, 2006
    US US 41132806 A
  • Priority: Apr 25, 2006
    US US 41132806 A
  • Priority: Apr 25, 2005
    US US 67502705 P

Download Citation


Sign in to the Lens

Feedback